REFERENCES
- Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am. J. Kidney Dis. 2002; 39: 930–936, [INFOTRIEVE], [CSA]
- Heyman SN, Rosen S. Dye Nephropathy. Semin. Nephrol. 2003; 23: 477–485, [INFOTRIEVE], [CSA], [CROSSREF]
- Heyman SN, Rosenberger C, Rosen S. Regional alterations in renal hemodynamics and oxygenation: a role in radiocontrast nephropathy. Nephrol. Dial. Transpl. 2005; 20(Suppl 1)i6–i11, [CSA], [CROSSREF]
- Rosenberger C, Heyman SN, Rosen S, et al. Upregulation of HIF in acute renal failure – evidence for a protective transcriptional response to hypoxia. Kidney Int. 2005; 67: 531–542, [INFOTRIEVE], [CSA], [CROSSREF]
- Agmon Y, Peleg H, Greenfeld Z, et al. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J. Clin. Invest. 1994; 94: 1069–1075, [INFOTRIEVE], [CSA]
- Heyman SN, Brezis M, Epstein FH, et al. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int. 1991; 40: 632–642, [INFOTRIEVE], [CSA]
- Beeri R, Symon Z, Brezis M, et al. Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int. 1995; 47: 1806–1810, [INFOTRIEVE], [CSA]
- Jelkmann W, Wagner K. Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Ann. Hematol. 2004; 83: 673–86, [INFOTRIEVE], [CSA], [CROSSREF]
- Heyman SN, Rosenberger C, Rosen S. Erythropoietin – a potential remedy for renal tubular injury?. Kidney Int. 2004; 65: 737–738, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Heyman SN, Fuchs S, Yafe R, et al. Renal microcirculation and tissue damage during acute ureteral obstruction: the effect of saline infusion, indomethacin and radiocontrast. Kidney Int. 1997; 51: 653–663, [INFOTRIEVE], [CSA]
- Maxwell P. HIF-1: an oxygen response system with special relevance to the kidney. J. Am. Soc. Nephrol. 2003; 14: 156–159, [CSA], [CROSSREF]
- Westenfelder C. Unexpected renal actions of erythropoietin. Exp. Nephrol. 2002; 10: 294–298, [INFOTRIEVE], [CSA], [CROSSREF]
- Fishbane S, Ragolia L, Palaia T, et al. Cytoprotection by Darbepoetin/Epoetin alfa in pig tubular and mouse mesangial cells. Kidney Int. 2004; 65: 452–458, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sharples EJ, Patel N, Brown P, et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J. Am. Soc. Nephrol. 2004; 15: 2115–2124, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Abdelrahman M, Sharples EJ, McDonald MC, et al. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 2004; 22: 63–69, [INFOTRIEVE], [CSA], [CROSSREF]
- Vesey DA, Cheung C, Pat B, et al. Erythropoietin protects against ischaemic acute renal injury. Nephrol. Dial. Transplant. 2004; 19: 348–355, [INFOTRIEVE], [CSA], [CROSSREF]
- Yang CW, Li C, Jung JY, et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in the rat kidney. FASEB J. 2003; 17: 1754–1755, [INFOTRIEVE], [CSA], [CROSSREF]
- Patel NS, Sharples EJ, Cuzzocrea S, et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int. 2004; 66: 983–989, [INFOTRIEVE], [CSA], [CROSSREF]
- Gong H, Wang W, Kwon TH, et al. EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney Int. 2004; 66: 683–695, [INFOTRIEVE], [CSA], [CROSSREF]
- Bagnis C, Beaufils H, Jacquiaud C, et al. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Nephrol. Dial. Transplant. 2001; 16: 932–938, [INFOTRIEVE], [CSA], [CROSSREF]
- Bahlmann FH, Song R, Boehm SM, et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 2004; 110: 1006–1012, [INFOTRIEVE], [CSA], [CROSSREF]
- Yang CW, Li C, Lim SW, et al. Recombinant human erythropoietin treatment protects chronic cyclosporine nephropathy: anti-apoptotic effect of rHuEPO. J. Am. Soc. Nephrol 2003; 14: 627A, [CSA]
- Gouva C, Nikolopoulos P, Ioannidis JP, et al. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int. 2004; 66: 753–760, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rogiers R, Zhang H, Leeman M, et al. Erythropietin response is blunted in critically ill patients. Intensive Care Med. 1997; 23: 159–163, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Darmon D, Goldfarb M, Shina A, et al. The effect of poly-(ADP-ribose) polymerase (PARP) inhibition on outer medullary hypoxic damage. Nephron. Physiol. 2003; 95: 1–9, [CSA], [CROSSREF]
- Brezis M, Kopolovic J, Rosen S. Hypoxic injury to medullary thick ascending limbs in perfused rat kidneys: reversible and irreversible phases. J. Electron. Microsc. Tech. 1988; 9: 293–298, [INFOTRIEVE], [CSA], [CROSSREF]
- Tojo A, Doumoto M, Oka K, Numabe A, Kimura K, Yagi S. Endothelin-mediated effect of erythropoietin on blood pressure and renal hemodynamics in hypertensive rats. Am. J. Physiol. 1996; 270: R744–R748, [INFOTRIEVE], [CSA]
- Zhang W, Edwards A. Oxygen transport across vasa recta in the renal medulla. Am. J. Physiol. 2002; 283: H1042–H1055, [CSA]
- Damianovich M, Ziv I, Heyman SN, Rosen S, Shina A, Kidron D, Aloya T, Grimberg H, Levin G, Reshef A, Bentolila A, Cohen A, Shirvan A. ApoSense: a novel technology for imaging of cell death in acute renal tubular necrosis. Eur. J. Nucl. Med. Mol. Im. 2006; 33: 281–291, [CSA], [CROSSREF]